Current Understanding of Mineral and Bone Disorders of Chronic Kidney Disease and the Scientific Grounds on the Use of Exogenous Parathyroid Hormone in Its Management
Michael Pazianas, Paul Dennis Miller
J Bone Metab. 2020;27(1):1-13.   Published online 2020 Feb 29     DOI: https://doi.org/10.11005/jbm.2020.27.1.1
Citations to this article as recorded by Crossref logo
Osteoporosis and Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD): Back to Basics
Michael Pazianas, Paul D. Miller
American Journal of Kidney Diseases.2021;[Epub]     CrossRef
Seasonal variation of serum 25-hydroxyvitamin D level in hemodialysis patients in the northernmost island of Japan
Yufu Gocho, Marenao Tanaka, Hirohito Sugawara, Masato Furuhashi, Norihito Moniwa, Tomohisa Yamashita, Hideki Takizawa, Hiroya Mukai, Kouhei Ohno, Takuto Maeda, Arata Osanami, Hirofumi Ohnishi, Hiroaki Komatsu, Kazuma Mori, Tetsuji Miura
Clinical and Experimental Nephrology.2021;[Epub]     CrossRef
Application prospects of glucagon-like peptide-1 receptor agonists in treatment of metabolic diseases
Qiang Zhang, Xiu-Fang Zhang, Chun-Yan Niu
World Chinese Journal of Digestology.2020; 28(11): 393.     CrossRef
Physical Activity-Dependent Regulation of Parathyroid Hormone and Calcium-Phosphorous Metabolism
Giovanni Lombardi, Ewa Ziemann, Giuseppe Banfi, Sabrina Corbetta
International Journal of Molecular Sciences.2020; 21(15): 5388.     CrossRef